Disease and clinical characteristics of patients with chronic myeloproliferative neoplasms: 11-year single center experience

Disease and clinical characteristics of patients with chronic myeloproliferative neoplasms: 11-year single center experience

Bibliographic Details
Main Authors:	P. Akyol, A. Yıldız, H. Afacan Öztürk, S. Maral, M. Reis Aras, F. Yılmaz, B. Saglam, M. Tıglıoglu, M. Albayrak
Format:	Article
Language:	English
Published:	Elsevier 2020-10-01
Series:	Hematology, Transfusion and Cell Therapy
Online Access:	http://www.sciencedirect.com/science/article/pii/S253113792030208X

Similar Items

Hypercalcemia due to the interaction between all trans retinoic acid and posaconazole used for acute promyelocytic leukemia treatment
by: H. Afacan Öztürk, et al.
Published: (2020-10-01)

Analysis of demographic and clinical characteristics of primary myelofibrosis and post-polycythemia vera/essential thrombocythemia myelofibrosis patients
by: P. Akyol, et al.
Published: (2020-10-01)

Does blood type have an effect on the course of COVID-19?
by: Mesut Tığlıoğlu, et al.
Published: (2022-06-01)

DOES BLOOD TYPE HAVE AN EFFECT ON THE COURSE OF COVID-19?
by: Fatma YILMAZ, et al.
Published: (2021-11-01)

CASE REPORT: FOLLICULAR LYMPHOMA PRESENTED WITH CHYLOTHORAX
by: Senem MARAL, et al.
Published: (2021-11-01)

Single Centre Experience: Bening and Malign Hematological Patients with COVID-19
by: Ümit Yavuz Malkan, et al.
Published: (2022-06-01)

CASE REPORT OF MARGINAL ZONE LYMPHOMA DETECTED WHILE INVESTIGATING ETIOLOGY FOR HEMOSTASIS DISORDER
by: Mesut Tığlıoğlu, et al.
Published: (2021-11-01)

A CASE OF STAGE 1E DIFFUSE LARGE B-CELL LYMPHOMA PRESENTED WITH KNEE INVOLVEMENT
by: Mesut Tığlıoğlu, et al.
Published: (2021-11-01)

RECURRENT AUTOIMMUNE HEMOLYTIC ANEMIA AFTER MRNA COVID-19 VACCINE (PFIZER-BIONTECH)
by: Fatma YILMAZ, et al.
Published: (2021-11-01)

A VERY RARE CAUSE OF DIARRHEA IN A CHEMOTHERAPY-INDUCED NEUTROPENIC PATIENT: PELLAGRA
by: Fatma YILMAZ, et al.
Published: (2021-11-01)

A RARE CAUSE OF ANEMIA IN ADULTHOOD CONGENITAL DYSERYTHROPETIC ANEMIA
by: Buğra Sağlam, et al.
Published: (2021-11-01)

A RARE CASE: POSTTRANSPLANT NK/T CELL LYMPHOMA
by: Pınar Tığlıoğlu, et al.
Published: (2021-11-01)

A RARE ASSOCIATION IN A CASE WITH HEREDITARY SPHEROCYTOSIS: SPECTRIN BETA (SPTB) AND JAK-2 MUTATION
by: Fatma YILMAZ, et al.
Published: (2021-11-01)

The prognostic impact of comorbidity, nutritional and performance status on patients with diffuse large B cell lymphoma
by: B. Saglam, et al.
Published: (2020-10-01)

The Impact of Hematological Parameters on Survival for Patients with COVID-19
by: Fatma YILMAZ, et al.
Published: (2022-12-01)

THE IMPACT OF HEMATOLOGICAL PARAMETERS ON SURVIVAL FOR PATIENTS WITH COVID-19
by: Fatma YILMAZ, et al.
Published: (2021-11-01)

INAPPROPRIATE ADH SYNDROME OCCURING DURING B-ALL TREATMENT
by: Merih Reis Aras, et al.
Published: (2021-11-01)

T-ACUTE MYELOID LEUKEMIA CASE THOUGHT TO BE ASSOCIATED WITH RADIOIODINE (I¹³¹) TREATMENT
by: Merih Reis Aras, et al.
Published: (2021-11-01)

An unusual case report: myeloid sarcoma presented with appendicitis
by: F. Yilmaz, et al.
Published: (2020-10-01)

THE RELATIONSHIP BETWEEN FERRITIN LEVEL AND THROMBOSIS IN PATIENTS WITH DIFFUSE LARGE B-CELL LYMPHOMA
by: Buğra Sağlam, et al.
Published: (2022-10-01)

ANTI-CD52 TREATMENT EXPERIENCE IN A T-CELL PROLYMPHOCYTIC LEUKEMIA PATIENT:CASE REPORT
by: Senem MARAL, et al.
Published: (2021-11-01)

THERAPEUTIC PLASMA EXCHANGE IN PATIENTS WITH NEUROLOGICAL DISEASES: A 9-YEAR, SINGLE-CENTER EXPERIENCE
by: Merih Reis Aras, et al.
Published: (2021-11-01)

Philadelphia-negative chronic myeloproliferative neoplasms
by: Rosane Isabel Bittencourt, et al.
Published: (2012-01-01)

Alk (−) anaplastic large cell lymphoma diagnosed by tongue root biopsy: case report
by: F. Yilmaz, et al.
Published: (2020-10-01)

Myeloproliferative neoplasms
by: Jean-Jacques Kiladjian
Published: (2018-06-01)

Myeloproliferative neoplasms
by: Nick Cross, (Coordinating Author)
Published: (2019-06-01)

Chronic Myeloproliferative Neoplasms: Some Remaining Challenges
by: Tariq I. Mughal, et al.
Published: (2018-10-01)

The microenvironment in myeloproliferative neoplasm
by: Simón Méndez-Ferrer, et al.
Published: (2018-06-01)

Spleen in myeloproliferative neoplasms
by: Giovanni Barosi
Published: (2018-06-01)

Aetiology of Myeloproliferative Neoplasms
by: Mary Frances McMullin, et al.
Published: (2020-07-01)

Epigenetics in myeloproliferative neoplasms
by: Graeme Greenfield, et al.
Published: (2023-07-01)

Multicenter Retrospective Analysis of Turkish Patients with Chronic Myeloproliferative Neoplasms
by: Nur Soyer, et al.
Published: (2017-02-01)

Vascular Diseases In Patients With Chronic Myeloproliferative Neoplasms – Impact Of Comorbidity
by: Frederiksen H, et al.
Published: (2019-11-01)

Interferons in the treatment of myeloproliferative neoplasms
by: Pankit Vachhani, et al.
Published: (2024-02-01)

Emerging Role of Neutrophils in the Thrombosis of Chronic Myeloproliferative Neoplasms
by: Francisca Ferrer-Marín, et al.
Published: (2021-01-01)

Myeloproliferative Neoplasms and Aspirin: Does Increased Platelet Turnover Matter?
by: Ilgın Koçak Göktürk, et al.
Published: (2023-03-01)

Methylation of SOCS3 in Myeloproliferative Neoplasms and Secondary Erythrocytosis/Thrombocythemia
by: Deniz Torun, et al.
Published: (2013-03-01)

Myeloproliferative neoplasm stem cells
by: Mead, A, et al.
Published: (2017)

Mutant Calreticulin in the Myeloproliferative Neoplasms
by: Daniel Prins, et al.
Published: (2020-02-01)

Neurological Findings in Myeloproliferative Neoplasms
by: Semra Paydas
Published: (2013-04-01)